Burning Rock Biotech (BNR) Accumulated Depreciation & Amortization: 2019-2024
- Burning Rock Biotech's Accumulated Depreciation & Amortization rose 15.87% to $65.9 million in Q4 2024 from the same period last year, while for Dec 2024 it was $195.4 million, marking a year-over-year increase of 26.29%. This contributed to the annual value of $7.2 million for FY2024, which is 61.94% down from last year.
- Per Burning Rock Biotech's latest filing, its Accumulated Depreciation & Amortization stood at $65.9 million for Q4 2024, which was up 15.87% from $56.9 million recorded in Q4 2023.
- In the past 5 years, Burning Rock Biotech's Accumulated Depreciation & Amortization ranged from a high of $65.9 million in Q4 2024 and a low of $18.2 million during Q4 2020.
- For the 3-year period, Burning Rock Biotech's Accumulated Depreciation & Amortization averaged around $48.8 million, with its median value being $48.6 million (2022).
- Data for Burning Rock Biotech's Accumulated Depreciation & Amortization shows a peak YoY spiked of 59.09% (in 2022) over the last 5 years.
- Burning Rock Biotech's Accumulated Depreciation & Amortization (Quarterly) stood at $18.2 million in 2020, then spiked by 38.49% to $25.3 million in 2021, then skyrocketed by 59.09% to $40.2 million in 2022, then soared by 41.57% to $56.9 million in 2023, then increased by 15.87% to $65.9 million in 2024.
- Its Accumulated Depreciation & Amortization was $65.9 million in Q4 2024, compared to $56.9 million in Q4 2023 and $40.2 million in Q4 2022.
